Skip to main content
. 2022 Jan 10;12:781425. doi: 10.3389/fphar.2021.781425

FIGURE 1.

FIGURE 1

There are various targets on lung cancer cells, among which VEGFR, αvβ3 Integrin, EGFR, σ Receptor, Folate Receptor, Transferrin Receptor and CD44 are important targets. The nanoparticles with specific ligand structure loaded with anticancer drugs specifically bind to the receptors on the surface of lung cancer and deliver the drugs to the cells.